Overview

  • Product name
    AAL 993
  • Description
    Potent, selective and cell-permeable VEGFR inhibitor
  • Biological description
    Potent, selective and cell-permeable VEGFR inhibitor (IC50 values are 130, 23 and 18 nM for VEGFR1, 2, and 3 respectively). Inhibits VEGF-induced angiogenesis in vivo. Suppresses hypoxia-induced HIF-1α expression without affecting Akt phosphorylation in vitro.
  • Purity
    > 98%

Properties

    References for AAL 993 (ab141590)

    This product has been referenced in:
    • Ban HS  et al. Suppression of hypoxia-induced HIF-1alpha accumulation by VEGFR inhibitors: Different profiles of AAL993 versus SU5416 and KRN633. Cancer Lett 296:17-26 (2010). Read more (PubMed: 20378243) »
    • Manley PW  et al. Advances in the structural biology, design and clinical development of VEGF-R kinase inhibitors for the treatment of angiogenesis. Biochim Biophys Acta 1697:17-27 (2004). Read more (PubMed: 15023347) »
    • Manley PW  et al. Anthranilic acid amides: a novel class of antiangiogenic VEGF receptor kinase inhibitors. J Med Chem 45:5687-93 (2002). Read more (PubMed: 12477352) »

    See 0 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab141590.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"

    Sign up